TipRanks
Go Ultimate55% OFF

Deltagen (DGEN) Financial Statements

Deltagen Financial Overview

Deltagen's market cap is currently $39. The company's EPS TTM is ―; its P/E ratio is 0.04; Deltagen has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 06Dec 05Dec 02Dec 01Dec 00
Income Statement
Total Revenue―――――
Gross Profit―――――
Operating Income$ 3.96M$ -461.00K$ -71.06M$ -52.16M$ -35.25M
EBITDA$ 4.00M$ -461.00K$ -96.19M$ -44.44M$ -30.19M
Net Income$ 4.37M$ -152.00K$ -107.17M$ -48.46M$ -32.22M
Balance Sheet
Cash & Short-Term Investments―――――
Total Assets$ 9.67M$ 15.73M$ 82.64M$ 109.05M$ 130.06M
Total Debt$ 0.00$ 0.00$ 15.56M$ 5.48M$ 4.89M
Net Debt$ -6.13M$ -11.56M$ 1.75M$ -71.00M$ -113.45M
Total Liabilities$ 840.00K$ 6.04M$ 51.95M$ 25.38M$ 19.20M
Stockholders' Equity―――――
Cash Flow
Free Cash Flow$ 2.00M―$ -84.84M$ -49.02M$ -17.35M
Operating Cash Flow―――――
Investing Cash Flow―――――
Financing Cash Flow―――――

Currency in USD